Related references
Note: Only part of the references are listed.A Meta-Analysis of Impact of Proton Pump Inhibitors on Antiplatelet Effect of Clopidogrel
Mao Chen et al.
CARDIOVASCULAR THERAPEUTICS (2012)
Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel
Michel Zabalza et al.
HEART (2012)
The platelet P2Y12 receptor for adenosine diphosphate: congenital and drug-induced defects
Marco Cattaneo
BLOOD (2011)
Clinical Events as a Function of Proton Pump Inhibitor Use, Clopidogrel Use, and Cytochrome P450 2C19 Genotype in a Large Nationwide Cohort of Acute Myocardial Infarction Results From the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Registry
Tabassome Simon et al.
CIRCULATION (2011)
Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention A Time-Dependent Analysis of the Gauging Responsiveness With a VerifyNow P2Y12 Assay: Impact on Thrombosis and Safety (GRAVITAS) Trial
Matthew J. Price et al.
CIRCULATION (2011)
Paraoxonase-1 Q192R Polymorphism and Antiplatelet Effects of Clopidogrel in Patients Undergoing Elective Coronary Stent Placement
Dietmar Trenk et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2011)
CYP2C19 But Not PON1 Genetic Variants Influence Clopidogrel Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy in Post-Myocardial Infarction Patients
Jean-Sebastien Hulot et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2011)
Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies
D. J. Angiolillo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting
Dirk Sibbing et al.
EUROPEAN HEART JOURNAL (2011)
Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting
Heleen J. Bouman et al.
HEART (2011)
Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention The GRAVITAS Randomized Trial
Matthew J. Price et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
High Residual Platelet Reactivity After Clopidogrel Loading and Long-term Cardiovascular Events Among Patients With Acute Coronary Syndromes Undergoing PCI
Guido Parodi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events A Systematic Review and Meta-analysis
Michael V. Holmes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
An Initial Experiment With Personalized Antiplatelet Therapy The GRAVITAS Trial
Paul A. Gurbel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Correlation between Light Transmission Aggregometry, VerifyNow P2Y12, and VASP-P Platelet Reactivity Assays Following Percutaneous Coronary Intervention
Michael A. Gaglia et al.
JOURNAL OF INTERVENTIONAL CARDIOLOGY (2011)
Clopidogrel-Drug Interactions
Eric R. Bates et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Impact of Platelet Reactivity on Clinical Outcomes After Percutaneous Coronary Intervention A Collaborative Meta-Analysis of Individual Participant Data
Somjot S. Brar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
High On-Treatment Platelet Reactivity After Prasugrel Loading Dose and Cardiovascular Events After Percutaneous Coronary Intervention in Acute Coronary Syndromes
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Prospective Evaluation of On-Clopidogrel Platelet Reactivity Over Time in Patients Treated With Percutaneous Coronary Intervention Relationship With Gene Polymorphisms and Clinical Outcome
Gianluca Campo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study
P. Fontana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Paraoxonase-1 is a major determinant of clopidogrel efficacy
Heleen J. Bouman et al.
NATURE MEDICINE (2011)
Paraoxonase-1 and clopidogrel efficacy
Thomas Cuisset et al.
NATURE MEDICINE (2011)
Paraoxonase-1 and clopidogrel efficacy reply
Heleen J. Bouman et al.
NATURE MEDICINE (2011)
Paraoxonase-1 and clopidogrel efficacy
Patrick M. Dansette et al.
NATURE MEDICINE (2011)
Paraoxonase-1 and clopidogrel efficacy
Jordi Camps et al.
NATURE MEDICINE (2011)
Diurnal variation in platelet inhibition by clopidogrel
Marek Kozinski et al.
PLATELETS (2011)
Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome
Fei-Yuan Hsiao et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Cytochrome P450 2C19☆2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis
F. Sofi et al.
PHARMACOGENOMICS JOURNAL (2011)
Stability of the high on-treatment platelet reactivity phenotype over time in clopidogrel-treated patients
Juliane Jaitner et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis
Tim Bauer et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Development of North American Consensus Guidelines for Medical Laboratories That Perform and Interpret Platelet Function Testing Using Light Transmission Aggregometry
Catherine P. M. Hayward et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Outcomes With Concurrent Use of Clopidogrel and Proton-Pump Inhibitors A Cohort Study
Wayne A. Ray et al.
ANNALS OF INTERNAL MEDICINE (2010)
Clopidogrel response: Head-to-head comparison of different platelet assays to identify clopidogrel non responder patients after coronary stenting
Thomas Cuisset et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2010)
Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet vasodilator-stimulated phosphoprotein flow cytometry
Nicolas von Beckerath et al.
BLOOD COAGULATION & FIBRINOLYSIS (2010)
Prognostic Modeling of Individual Patient Risk and Mortality Impact of Ischemic and Hemorrhagic Complications Assessment From the Acute Catheterization and Urgent Intervention Triage Strategy Trial
Stuart J. Pocock et al.
CIRCULATION (2010)
New P2Y12 Inhibitors
Marco Cattaneo
CIRCULATION (2010)
Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies The RESPOND Study
Paul A. Gurbel et al.
CIRCULATION (2010)
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents
Neena S. Abraham et al.
CIRCULATION (2010)
Medication Adherence in Cardiovascular Disease
Steven Baroletti et al.
CIRCULATION (2010)
Long-Term Aspirin and Clopidogrel Response Evaluated by Light Transmission Aggregometry, VerifyNow, and Thrombelastography in Patients Undergoing Percutaneous Coronary Intervention
Esben Hjorth Madsen et al.
CLINICAL CHEMISTRY (2010)
Guidelines on myocardial revascularization The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
William Wijns et al.
EUROPEAN HEART JOURNAL (2010)
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI A Meta-analysis
Jessica L. Mega et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation
Nicoline J. Breet et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
The Influence of Proton Pump Inhibitors on the Antiplatelet Potency of Clopidogrel Evaluated by 5 Different Platelet Function Tests
Thomas Gremmel et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes
Roxana Mehran et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Long-Term Clinical Outcome Based on Aspirin and Clopidogrel Responsiveness Status After Elective Percutaneous Coronary Intervention A 3T/2R (Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel) Trial Substudy
Gianluca Campo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration A Systematic Meta-Analysis
Jean-Sebastien Hulot et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Impact of Cytochrome P450 2C19 Loss-of-Function Polymorphism and of Major Demographic Characteristics on Residual Platelet Function After Loading and Maintenance Treatment With Clopidogrel in Patients Undergoing Elective Coronary Stent Placement
Willibald Hochholzer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA Boxed Warning A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association
David R. Holmes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Platelet Aggregation and Its Association With Stent Thrombosis and Bleeding in Clopidogrel-Treated Patients Initial Evidence of a Therapeutic Window
Dirk Sibbing et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis
J. M. Siller-Matula et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis
Jessica L. Mega et al.
LANCET (2010)
Clopidogrel with or without Omeprazole in Coronary Artery Disease.
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of CYP2C19 Genotype on Outcomes of Clopidogrel Treatment
Guillaume Pare et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Intra-individual variability in clopidogrel responsiveness in coronary artery disease patients under long term therapy
Sebastien Armero et al.
PLATELETS (2010)
Comparative Effectiveness Research and Personalized Medicine Catalyzing or Colliding?
Robert S. Epstein et al.
PHARMACOECONOMICS (2010)
Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients
Rita Paniccia et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Acute and Subacute Stent Thrombosis
Laurent Bonello et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Methods for the Measurement of Platelet Function
Alan D. Michelson
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Can We Override Clopidogrel Resistance?
Ana Pena et al.
CIRCULATION (2009)
Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary Syndrome
Jeremy A. Rassen et al.
CIRCULATION (2009)
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial
Alan D. Michelson et al.
EUROPEAN HEART JOURNAL (2009)
Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
P. Michael Ho et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
Alan R. Shuldiner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH
M. Cattaneo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
CYP2C19*2 polymorphism is not the sole determinant of the response to clopidogrel: implications for its monitoring
B. Aleil et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
Michelle L. O'Donoghue et al.
LANCET (2009)
Clopidogrel 150 mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention Results From the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) Randomized Study
Boris Aleil et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2008)
Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: A multicenter randomized prospective study
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin
Martine Gilard et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients
R. Paniccia et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection
M. Cattaneo
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Replicating genotype-phenotype associations
Stephen J. Chanock et al.
NATURE (2007)
Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin
M. Gilard et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Adverse impact of bleeding on prognosis in patients with acute coronary syndromes
John W. Eikelboom et al.
CIRCULATION (2006)
Heparin and low-molecular-weight heparin - The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
J Hirsh et al.
CHEST (2004)
Aspirin and clopidogrel - Efficacy, safety, and the issue of drug resistance
M Cattaneo
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Replication validity of genetic association studies
JPA Ioannidis et al.
NATURE GENETICS (2001)
The oral anticoagulant saga: Past, present, and future
BM Duxbury et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2001)
Share Paper
